Lataa...
The need to accelerate access to new drugs for multidrug-resistant tuberculosis
Approximately half a million people are thought to develop multidrug-resistant tuberculosis annually. Barely 20% of these people currently receive recommended treatment and only about 10% are successfully treated. Poor access to treatment is probably driving the current epidemic, via ongoing transmi...
Tallennettuna:
| Julkaisussa: | Bull World Health Organ |
|---|---|
| Päätekijät: | , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
World Health Organization
2015
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4490806/ https://ncbi.nlm.nih.gov/pubmed/26170507 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2471/BLT.14.138925 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|